Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab
Crossref DOI link: https://doi.org/10.1038/s41397-019-0073-5
Published Online: 2019-01-18
Published Print: 2020-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Magnes, T.
Melchardt, T.
Hufnagl, C.
Weiss, L.
Mittermair, C.
Neureiter, D.
Klieser, E.
Rinnerthaler, G.
Roesch, S.
Gaggl, A.
Greil, R.
Egle, A.
Text and Data Mining valid from 2019-01-18
Article History
First Online: 18 January 2019